YU41738B - Process for obtaining 1,2,4-oxadiazoline-5-one derivatives - Google Patents

Process for obtaining 1,2,4-oxadiazoline-5-one derivatives

Info

Publication number
YU41738B
YU41738B YU2594/80A YU259480A YU41738B YU 41738 B YU41738 B YU 41738B YU 2594/80 A YU2594/80 A YU 2594/80A YU 259480 A YU259480 A YU 259480A YU 41738 B YU41738 B YU 41738B
Authority
YU
Yugoslavia
Prior art keywords
oxadiazoline
derivatives
obtaining
Prior art date
Application number
YU2594/80A
Other languages
English (en)
Other versions
YU259480A (en
Inventor
K Takacs
I Kiss-Ajzert
A Simay
Nagy P Literati
M Hetyey-Papp
M Escery-Puskas
L Szekeres
G Papp
S Viragh
E Udvardy
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of YU259480A publication Critical patent/YU259480A/xx
Publication of YU41738B publication Critical patent/YU41738B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
YU2594/80A 1979-10-11 1980-10-10 Process for obtaining 1,2,4-oxadiazoline-5-one derivatives YU41738B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79CI1973A HU179951B (en) 1979-10-11 1979-10-11 Process for preparing 1,2,4-oxadiazolin-5-one derivatives and pharmaceutical compositions containing thereof

Publications (2)

Publication Number Publication Date
YU259480A YU259480A (en) 1984-02-29
YU41738B true YU41738B (en) 1987-12-31

Family

ID=10994764

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2594/80A YU41738B (en) 1979-10-11 1980-10-10 Process for obtaining 1,2,4-oxadiazoline-5-one derivatives

Country Status (23)

Country Link
US (1) US4365064A (sv)
JP (1) JPS5661375A (sv)
AT (1) AT375369B (sv)
BE (1) BE885633A (sv)
CA (1) CA1154019A (sv)
CH (1) CH649547A5 (sv)
CS (1) CS241032B2 (sv)
DD (1) DD153550A5 (sv)
DE (1) DE3037432A1 (sv)
DK (1) DK149854C (sv)
ES (1) ES8106725A1 (sv)
FI (2) FI71318C (sv)
FR (1) FR2467203A1 (sv)
GB (1) GB2059967B (sv)
HU (1) HU179951B (sv)
IL (1) IL61175A (sv)
IT (1) IT1129305B (sv)
NL (1) NL8005586A (sv)
NO (1) NO154795C (sv)
PL (3) PL131451B1 (sv)
SE (1) SE452158B (sv)
SU (1) SU1087519A1 (sv)
YU (1) YU41738B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU180708B (en) * 1979-10-11 1983-04-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 1,2,4-oxadiazine derivatives
DK1268407T3 (da) * 2000-03-20 2004-09-06 N Gene Res Lab Inc Propencarboxylsyreamidoximderivater, fremgangsmåde til deres fremstilling samt lægemidler indeholdende disse
DK2935222T3 (en) 2012-12-21 2019-01-07 Epizyme Inc PRMT5 INHIBITORS AND APPLICATIONS THEREOF
CA2899363A1 (en) * 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
JP2016505000A (ja) 2012-12-21 2016-02-18 エピザイム,インコーポレイティド Prmt5阻害剤およびその使用
WO2014100734A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
US9745291B2 (en) 2012-12-21 2017-08-29 Epizyme, Inc. PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
EP3177288A4 (en) 2014-08-04 2018-04-04 Epizyme, Inc. Prmt5 inhibitors and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1529700A (fr) * 1967-04-11 1968-06-21 Dausse Sa Lab Tertioaminoalcoyl oxadiazolinones et leur procédé de préparation
FR1575552A (sv) * 1967-12-07 1969-07-25
US4038279A (en) * 1972-12-23 1977-07-26 Boehringer Ingelheim Gmbh N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof
US3994891A (en) * 1974-12-20 1976-11-30 Armour Pharmaceutical Company Tetrahydroisoquinoline compounds
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
HU180708B (en) * 1979-10-11 1983-04-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 1,2,4-oxadiazine derivatives

Also Published As

Publication number Publication date
SE452158B (sv) 1987-11-16
NL8005586A (nl) 1981-04-14
PL232293A1 (sv) 1982-04-26
DK149854B (da) 1986-10-13
NO154795C (no) 1986-12-29
DK429780A (da) 1981-04-12
BE885633A (fr) 1981-02-02
DK149854C (da) 1987-04-21
YU259480A (en) 1984-02-29
PL227209A1 (sv) 1981-12-11
DE3037432A1 (de) 1981-05-27
NO803044L (no) 1981-04-13
PL131451B1 (en) 1984-11-30
FR2467203A1 (fr) 1981-04-17
CH649547A5 (de) 1985-05-31
CS241032B2 (en) 1986-03-13
NO154795B (no) 1986-09-15
JPS5661375A (en) 1981-05-26
FI803220L (fi) 1981-04-12
SE8007025L (sv) 1981-04-12
IL61175A (en) 1984-08-31
IT1129305B (it) 1986-06-04
CS673780A2 (en) 1985-06-13
ES495819A0 (es) 1981-09-16
PL132131B1 (en) 1985-02-28
ATA501380A (de) 1983-12-15
FI71318B (fi) 1986-09-09
GB2059967B (en) 1983-06-02
FR2467203B1 (sv) 1985-03-22
IL61175A0 (en) 1980-11-30
FI803219L (fi) 1981-04-12
IT8068555A0 (it) 1980-10-09
PL131375B1 (en) 1984-11-30
CA1154019A (en) 1983-09-20
GB2059967A (en) 1981-04-29
FI71932C (sv) 1987-03-09
HU179951B (en) 1983-01-28
PL232292A1 (sv) 1982-04-26
FI71318C (fi) 1986-12-19
US4365064A (en) 1982-12-21
ES8106725A1 (es) 1981-09-16
DD153550A5 (de) 1982-01-13
AT375369B (de) 1984-07-25
SU1087519A1 (ru) 1984-04-23
FI71932B (fi) 1986-11-28

Similar Documents

Publication Publication Date Title
YU289180A (en) Process for preparing alfa-aryl-1h-1,2,4-triazole-1-ethanols
YU43116B (en) Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
YU42064B (en) Process for obtaining new glycevol derivatives
YU201180A (en) Process for preparingnew 2,4,6-triiodo-isophalic acid derivatives
RO84151B (ro) Procedeu de preparare a unor derivati de penicilanoiloximetilpenicilanat 1,1-dioxid
HU182185B (en) Process for preparing 5-substituted 2,3-diaryl-thiophene derivatives
YU56680A (en) Process for obtaining new 1,2,4-triazole derivatives
PT72176B (en) Process for preparing 2,3-indoledione derivatives
DE3070919D1 (en) Process for preparing 1,3,7-trialkylxanthines
YU42323B (en) Process for obtaining 3,5-dichloraniline
YU259480A (en) Process for obtaining 1,2,4-oxdiaoline-5-one derivatives
YU145480A (en) Process for obtaining new hydroxyamino-eburnane derivatives
YU298779A (en) Process for preparing 2,6-dialkyl-n-alkoxymethyl-2-chloroacetanilides
YU236180A (en) Process for obtaining 15-sulfonamido-prostaglandin derivatives
HU173509B (hu) Sposob poluchenija proizvodnykh 1,2-benzo-tiazin-3-karboksamida
YU298180A (en) Process for preparing 5,10-dihydroimidazo-2,1-quinazoline
YU188180A (en) Process for obtaining new nitroalkanol derivatives
YU259580A (en) Process for obtaining 1,2,4-oxadiazine derivatives
YU57478A (en) Process for obtaining 1,2,3-thiadiazoline-2-ide derivatives
YU100280A (en) Process for obtaining new aminoisoquinazoline derivatives
YU122280A (en) Process for obtaining 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)-pyrimidin-4-one derivatives
YU49480A (en) Process for obtaining new pyrido-(3,4-e)-as-triazine derivatives
YU307680A (en) Process for obtaining 2,5-dialkyl-phenyl carbamide derivatives
PL116331B2 (en) Process for preparing 2,2,5,9-tetramethyldecadi-4,8-en-1-al
YU42840B (en) Process for obtaining new indolysine derivatives